Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Regular ✕HDFC INNOVATION FUND · Regular ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundHDFC INNOVATION FUND
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseTataHDFC
NAV₹33.9323₹12.0990
NAV date20 Nov 202620 Nov 2026
History10.9 years1.3 years
Expense ratio2.4%2.1%
Stars★★★★★Not rated
Growth Score65.70—

Returns

Tata India Pharma & Healthcare FundHDFC INNOVATION FUND
1 month+9.73%+7.44%
3 months+0.76%+1.83%
6 months+6.88%+17.44%
YTD+12.33%+18.49%
1 year+10.25%+15.37%
3 years (CAGR)+17.02%—
5 years (CAGR)+14.30%—
10 years (CAGR)+14.17%—
Since launch+11.82%+15.12%

Risk

Tata India Pharma & Healthcare FundHDFC INNOVATION FUND
Volatility15.7%—
Downside volatility10.1%—
Sharpe0.67—
Sortino1.04—
Calmar1.00—
Return / risk1.09—
Deepest fall−21.94%−12.75%
Days to recover62457
Below its high−0.20%−0.51%

Against benchmark

Tata India Pharma & Healthcare FundHDFC INNOVATION FUND
Alpha−4.21%—
Beta1.00—
R²90.2%—
Up capture88.9%—
Down capture105.4%—
Tracking error4.9%—
Information ratio−0.87—
Treynor0.09—

Consistency

Tata India Pharma & Healthcare FundHDFC INNOVATION FUND
Best 1-year+73.72%+21.37%
Middle 1-year+7.27%+14.84%
Worst 1-year−18.70%+4.37%
1-year periods with a loss33.4%0.0%
Middle 3-year+19.29%—
Positive months61.1%—
Best day+3.33%+2.83%
Worst day−3.10%−2.93%
Worst 5% day−1.35%−1.47%
Positive days54.9%54.2%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundHDFC INNOVATION FUND
5-year XIRR+16.33%—
5-year value₹9,09,680—
3-year XIRR+11.67%—
1-year XIRR+16.78%+26.82%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth